An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models
about
An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@en
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@nl
type
label
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@en
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@nl
prefLabel
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@en
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@nl
P2093
P2860
P1476
An anti-ASCT2 monoclonal antib ...... toxicity in preclinical models
@en
P2093
Aya Osanai-Sasakawa
Kazuya Yamano
Kenta Hosomi
Minami Imaizumi
Noriyuki Kasai
Ryuichiro Nakai
Satoshi Nakamura
Shiho Tomura-Suruki
Takuya Takizawa
P2860
P304
P407
P577
2018-01-01T00:00:00Z